John V. Talley
Chief Executive Officer at Mitotherapeutix LLC
Network origin in John V. Talley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY.
20
| Extinct | Pharmaceuticals: Major | 20 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ.
11
| Extinct | Miscellaneous Commercial Services | 11 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV.
6
| Extinct | Financial Conglomerates | 6 |
Mitotherapeutix LLC
 Mitotherapeutix LLC BiotechnologyHealth Technology Mitotherapeutix LLC develops products for treatment of diseases by modifying or influencing metabolic pathways in the cell. The company is headquartered in Cheshire, CT.
4
| Holding Company | Biotechnology | 4 |
IGF Oncology LLC
 IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN.
1
| Private Company | Biotechnology | 1 |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John V. Talley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SYNVISTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DIGI INTERNATIONAL INC. | Telecommunications Equipment | Director/Board Member | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Sparta Pharmaceuticals, Inc.
 Sparta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Sparta Pharmaceuticals, Inc. acquires the rights to, and develops for commercialization, technologies and drugs for the treatment of diseases. The company is based in Horsham, PA. Sparta Pharmaceuticals was acquired by SuperGen, Inc. on August 13, 1999 for $12.28 million. The company was founded by Peter N. Christos. | Pharmaceuticals: Major | Director/Board Member | |
| CYBERONICS, INC. | Medical Specialties | Director/Board Member | |
| UROLOGIX, INC. | Medical Specialties | Director/Board Member | |
| University of Nebraska | College/University | Undergraduate Degree | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
SCP Vitalife Partners
 SCP Vitalife Partners Investment ManagersFinance SCP Vitalife Partners (SCP Vitalife) is a venture capital firm founded in 2000 by Dr. Abraham Ludomirski and Wayne B. Weisman. The firm is headquartered in Malvern, Philadelphia with additional office in Israel. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| Bryant University | College/University | Masters Business Admin Masters Business Admin | |
| New York University | College/University | Graduate Degree Masters Business Admin | |
Malvern Consulting Group, Inc.
 Malvern Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| CORMEDIX INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Organon International, Inc.
 Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
| University of Mumbai | College/University | Undergraduate Degree Undergraduate Degree | |
| Pace University | College/University | Masters Business Admin Undergraduate Degree | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
Leversense LLC
 Leversense LLC Medical/Nursing ServicesHealth Services Leversense LLC develops next generation diagnostic biosensor technology. It intends to develop a medical device for detecting AIDS, food toxin, and mycoplasma bacteria. The company was founded by Pete A. Nagy in 2006 and is headquartered in Newtown Square, PA. | Medical/Nursing Services | Director/Board Member | |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Pharmaceuticals: Other | Chief Executive Officer | |
Biophage Pharma, Inc.
 Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| Yeshiva University | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| LIFE TIME FITNESS, INC. | Movies/Entertainment | Director/Board Member | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Corporate Secretary | |
| Harvard Business School | College/University | Masters Business Admin | |
SCP Private Equity Partners
 SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | Investment Managers | Private Equity Investor | |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Pharmaceuticals: Major | General Counsel | |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Pharmaceuticals: Major | Director/Board Member | |
| FUNCTIONAL TECHNOLOGIES CORP | Food: Major Diversified | Chairman |
Statistics
International
| United States | 44 |
| Canada | 3 |
| Israel | 2 |
| India | 2 |
| France | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Finance | 4 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 159 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 49 |
| President | 38 |
| Chief Tech/Sci/R&D Officer | 33 |
Most connected contacts
| Insiders | |
|---|---|
| Alan Dunton | 34 |
| Wayne P. Yetter | 28 |
| Rosemary Mazanet | 24 |
| C. Nicholson | 22 |
| Dick L. Sherman | 21 |
| Robert G. Savage | 19 |
| Gerri Henwood | 16 |
| Fenel Eloi | 16 |
| Sergio Traversa | 15 |
| Mark James Docherty | 14 |
| Robert J. Hennessey | 13 |
| Bob Cook | 11 |
| Dragan Cicic | 11 |
| Keith Brownlie | 10 |
| Sandesh Seth | 10 |
- Stock Market
- Insiders
- John V. Talley
- Company connections
